ST. LOUIS, July 27 /PRNewswire-FirstCall/ -- Centene Corporation (NYSE: CNC) today announced net earnings from continuing operations for the quarter ended June 30, 2010, of $23.0 million, or $0.45 per diluted share.  The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

Second Quarter Highlights

  • Quarter-end managed care at-risk membership of 1,531,800, an increase of 242,800 members, or 18.8% year over year.
  • Premium and Service Revenues of $1.051 billion, representing 12.8% year over year growth.
  • Health Benefits Ratio (HBR) of 83.8%, compared to 83.1% in the prior year.  
  • General and Administrative (G&A) expense ratio of 12.7%, compared to 13.9% in the prior year.
  • Earnings from operations of $41.7 million, compared to $31.4 million in the prior year.
  • Earnings from continuing operations, net of income tax expense, increased 11.0% year over year to $23.0 million.  Within the quarter, we incurred a $0.03 charge per diluted share to write off a deferred tax asset associated with our Georgia health plan and benefited by $0.03 per diluted share from a shift in start up costs for Mississippi from the second to the third quarter.  
  • Diluted earnings per share from continuing operations of $0.45.  
  • Days in claims payable of 48.2, including pharmacy claims payable.
  • Estimated 2010 composite premium rate increase between 1% and 3%.


Other Events

  • In May 2010, our Texas health plan was awarded a new ABD contract in the Dallas service area subject to execution of a final contract.  The new contract is expected to commence during the first quarter of 2011.  
  • In June 2010, we completed the acquisition of certain assets of Carolina Crescent Health Plan.  We now serve 92,600 at-risk members in South Carolina as of June 30, 2010.  
  • In June 2010, our Indiana health plan was selected to negotiate a statewide managed care contract effective January 1, 2011.  Upon successful execution of the contract, we will continue to serve Hoosier Healthwise members and begin serving Healthy Indiana Plan members.  
  • In July 2010, we closed on the acquisition of certain assets of NovaSys Health, LLC, a leading third party administrator in Arkansas that will complement our existing Celtic business.  


Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, “Our team continues to focus on fundamentals and driving Centene to be a low-cost producer. These are key factors in producing another solid quarterly report and for the long-term success of our enterprise.”

The following table depicts membership in Centene’s managed care organizations, by state, at June 30, 2010 and 2009:





June 30,





2010



2009

Arizona



19,300



16,200

Florida



113,100



22,300

Georgia



295,600



292,800

Indiana



212,700



196,100

Massachusetts



30,100



Ohio



159,300



141,200

South Carolina



92,600



46,000

Texas



475,500



443,200

Wisconsin



133,600



131,200

Total at-risk membership



1,531,800



1,289,000

Non-risk membership



50,900



114,000

Total



1,582,700



1,403,000





The following table depicts membership in Centene’s managed care organizations, by member category, at June 30, 2010 and 2009:





June 30,





2010



2009

Medicaid



1,135,500



958,600

CHIP & Foster Care



272,400



261,400

ABD & Medicare



93,800



69,000

Other State programs



30,100



Total at-risk membership



1,531,800



1,289,000

Non-risk membership



50,900



114,000

Total



1,582,700



1,403,000





Statement of Operations

  • Premium and service revenues increased 12.8% for the three months ended June 30, 2010 over 2009 as a result of membership growth in each of our states.  This increase was moderated by the removal of pharmacy services in two states beginning in 2010.  These pharmacy carve outs had the effect of reducing 2010 second quarter revenue by approximately $48 million.
  • The consolidated HBR for the three months ended June 30, 2010 of 83.8% was an increase of 0.7% over the comparable period in 2009.  A reconciliation of the change in HBR from the prior year is presented below:




Second Quarter 2009

83.1%



New markets reserved at higher rates

0.6



Net changes in existing markets

0.1



Second Quarter 2010

83.8%















  • Consolidated G&A expense as a percent of premium and service revenues was 12.7% in the second quarter of 2010, a decrease from 13.9% in the second quarter of 2009.  The decrease reflects the leveraging of our expenses over higher revenues and the impact of our ongoing focus on system enhancements and operational efficiencies.  Additionally, we benefited by $0.03 per diluted share from a shift in start up costs for Mississippi from the second to the third quarter.
  • Effective July 1, 2010, our Georgia health plan will begin paying premium taxes and will no longer be subject to income taxes.  Accordingly, the deferred tax asset related to state net operating loss carry forwards was written off.  The write off increased income tax expense during the second quarter by $1.7 million, or $0.03 per diluted share.
  • Earnings per diluted share from continuing operations were $0.45, compared to $0.47 in the second quarter of 2009.  


Balance Sheet and Cash Flow

At June 30, 2010, we had cash and investments of $852.4 million, including $813.0 million held by our regulated entities and $39.4 million held by our unregulated entities.  Medical claims liabilities totaled $455.4 million, representing 48.2 days in claims payable, an increase of 0.5 days from March 31, 2010.  Total debt was $252.8 million and debt to capitalization was 24.5%.  

Cash flow from operations through June 30, 2010 was $(98.3) million and was impacted by 1) $86.0 million decrease in unearned revenue due to advance payments received in December 2009 for January 2010 premium payments and 2) $57.7 million increase in premium and related receivables for June premium payments deferred by several states until July 2010.  During the second half of 2010, we expect cash flow from operations to return to historical levels, although the timing of premium payments from each state can vary from period to period.

A reconciliation of the change in days in claims payable from the immediately preceding quarter-end is presented below:

Days in claims payable, March 31, 2010

47.7



  Timing of claims payments

0.8



  Payment of annual provider bonuses

(0.5)



  Impact of new business

0.3



  Pharmacy payment timing

(0.1)



Days in claims payable, June 30, 2010

48.2









Outlook

The table below depicts our guidance from continuing operations for 2010:





Full Year 2010







Low



High 



Premium and Service revenues (in millions)



$    4,350



$  4,450



Earnings per diluted share (EPS)



$    1.78



$  1.86



HBR %



83.5%



84.5%



G&A %



12.4%



12.9%















Diluted Shares Outstanding (in thousands)



50,500



















Based upon known rate adjustments and preliminary discussions with our states that finalize rates in the second half of the year, we currently estimate our 2010 composite premium rate increase to be between 1% and 3%.

Conference Call

As previously announced, we will host a conference call Tuesday, July 27, 2010, at 8:30 A.M. (Eastern Time) to review the financial results for the second quarter ended June 30, 2010, and to discuss our business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  

Investors and other interested parties are invited to listen to the conference call by dialing 800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad; or via a live, audio webcast on our website at www.centene.com, under the Investors section.

A replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, July 26, 2011, at the aforementioned URL, or by dialing 877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad and entering the playback conference number 442132.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company’s estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Actual results may differ from projections or estimates due to a variety of important factors, including Centene’s ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare.  The expiration, cancellation or suspension of Centene’s Medicaid Managed Care contracts by state governments would also negatively affect Centene.  

Tables Follow





CENTENE CORPORATION AND SUBSIDIARIES



CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)





June 30,

2010



December 31,

2009



ASSETS













Current assets:













   Cash and cash equivalents of continuing operations, including $5,154 and $8,667, respectively, from

    consolidated variable interest entities



$

264,723

$

400,951



   Cash and cash equivalents of discontinued operations





877



2,801



   Total cash and cash equivalents





265,600



403,752



   Premium and related receivables, net of allowance for uncollectible accounts of $1,336 and $1,338,

    respectively, including $7,266 and $11,313, respectively, from consolidated variable interest entities





164,420



103,456



   Short-term investments, at fair value (amortized cost $29,542 and $39,230, respectively)





29,660



39,554



   Other current assets, including $3,918 and $4,507, respectively, from consolidated variable interest entities





83,843



64,866



   Current assets of discontinued operations other than cash





2,314



4,506



       Total current assets





545,837



616,134



Long-term investments, at fair value (amortized cost $522,589 and $514,256, respectively)





537,399



525,497



Restricted deposits, at fair value (amortized cost $20,485 and $20,048, respectively)





20,570



20,132



Property, software and equipment, net of accumulated depreciation of $118,995 and $103,883, respectively,

including $138,998 and $89,219, respectively, from consolidated variable interest entities





313,839



230,421



Goodwill





244,304



224,587



Intangible assets, net





24,589



22,479



Other long-term assets





35,557



36,829



Long-term assets of discontinued operations





11,442



26,285



       Total assets



$

1,733,537

$

1,702,364



LIABILITIES AND STOCKHOLDERS' EQUITY













Current liabilities:













   Medical claims liability



$

455,375

$

470,932



   Accounts payable and accrued expenses, including $30,366 and $14,020, respectively, from consolidated

    variable interest entities





167,613



132,001



   Unearned revenue





5,695



91,644



   Current portion of long-term debt





771



646



   Current liabilities of discontinued operations





7,365



20,685



       Total current liabilities





636,819



715,908



Long-term debt





252,028



307,085



Other long-term liabilities





64,870



59,561



Long-term liabilities of discontinued operations





652



383



       Total liabilities





954,369



1,082,937

















Commitments and contingencies



























Stockholders' equity:













   Common stock, $.001 par value; authorized 100,000,000 shares; 51,654,541 issued and 49,210,505

     outstanding at June 30, 2010, and 45,593,383 shares issued and 43,179,373 shares outstanding at

      December 31, 2009





52



46



   Additional paid-in capital





395,926



281,806



   Accumulated other comprehensive income:













    Unrealized gain on investments, net of tax





9,400



7,348



   Retained earnings





405,682



358,907



   Treasury stock, at cost (2,444,036 and 2,414,010 shares, respectively)





(47,830)



(47,262)



   Total Centene Corporation stockholders' equity





763,230



600,845



   Noncontrolling interest





15,938



18,582



       Total stockholders' equity





779,168



619,427



       Total liabilities and stockholders' equity



$

1,733,537

$

1,702,364









CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share data)

(Unaudited)



Three Months Ended

June 30,



Six Months Ended

June 30,





2010





2009



2010





2009



Revenues:





























   Premium

$

1,025,928





$

909,698



$

2,025,243





$

1,794,704



   Service



24,682







21,591





47,589







45,440



       Premium and service revenues



1,050,610







931,289





2,072,832







1,840,144



   Premium tax



26,162







108,180





72,661







131,760



       Total revenues



1,076,772







1,039,469





2,145,493







1,971,904



Expenses:





























   Medical costs



859,335







755,706





1,699,043







1,495,046



   Cost of services



15,707







14,559





32,859







30,521



   General and administrative expenses



133,470







129,221





268,977







251,500



   Premium tax



26,551







108,548





73,294







132,490



       Total operating expenses



1,035,063







1,008,034





2,074,173







1,909,557



       Earnings from operations



41,709







31,435





71,320







62,347



Other income (expense):





























   Investment and other income



4,142







4,418





11,199







8,031



   Interest expense



(3,869)







(4,160)





(7,682)







(8,146)



       Earnings from continuing operations, before income

        tax expense



41,982







31,693





74,837







62,232



   Income tax expense



17,254







11,789





29,779







22,634



       Earnings from continuing operations, net of income

        tax expense



24,728







19,904





45,058







39,598



Discontinued operations, net of income tax (benefit)

expense of $(90), $(196), $4,350 and $(356),

 respectively



(226)







(485)





3,694







(934)



       Net earnings



24,502







19,419





48,752







38,664



Noncontrolling interest (loss)



1,729







(811)





1,977







(24)



       Net earnings attributable to Centene Corporation

$

22,773





$

20,230



$

46,775





$

38,688

































Amounts attributable to Centene Corporation common

stockholders:





























   Earnings from continuing operations, net of income tax

   expense

$

22,999





$

20,715



$

43,081





$

39,622



   Discontinued operations, net of income tax (benefit)

    expense



(226)







(485)





3,694







(934)



   Net earnings

$

22,773





$

20,230



$

46,775





$

38,688

































Net earnings (loss) per common share attributable to

Centene Corporation:





























   Basic:





























    Continuing operations

$

0.46





$

0.48



$

0.89





$

0.92



    Discontinued operations









(0.01)





0.08







(0.02)



    Earnings per common share

$

0.46





$

0.47



$

0.97





$

0.90



   Diluted:





























     Continuing operations

$

0.45





$

0.47



$

0.86





$

0.90



     Discontinued operations









(0.01)





0.08







(0.02)



     Earnings per common share

$

0.45





$

0.46



$

0.94





$

0.88

































Weighted average number of shares outstanding:





























     Basic



49,135,552







43,001,157





48,203,312







43,034,390



     Diluted



50,866,318







44,242,339





49,807,084







44,240,071









CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



Six Months Ended June 30,





2010



2009

















Cash flows from operating activities:













   Net earnings

$

48,752



$

38,664



   Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:













     Depreciation and amortization



24,918





20,892



     Stock compensation expense



6,888





7,611



     (Gain) loss on sale of investments, net



(3,987)





450



     (Gain) on sale of UHP



(8,201)





--



     Deferred income taxes



4,928





1,512



   Changes in assets and liabilities:













     Premium and related receivables



(57,718)





(23,327)



     Other current assets



948





1,357



     Other assets



1,719





(608)



     Medical claims liabilities



(28,868)





17,093



     Unearned revenue



(85,950)





44,129



     Accounts payable and accrued expenses



(3,536)





(49,377)



     Other operating activities



1,851





3,723



         Net cash (used in) provided by operating activities



(98,256)





62,119



Cash flows from investing activities:













   Capital expenditures



(63,602)





(29,833)



   Purchases of investments



(306,124)





(415,052)



   Proceeds from asset sales



13,420





--



   Sales and maturities of investments



291,735





377,320



   Investments in acquisitions, net of cash acquired



(21,473)





(7,621)



         Net cash used in investing activities



(86,044)





(75,186)



Cash flows from financing activities:













   Proceeds from exercise of stock options



1,759





1,109



   Proceeds from borrowings



42,161





288,000



   Proceeds from stock offering



104,534





--



   Payment of long-term debt



(97,193)





(264,135)



   Distributions to noncontrolling interest



(4,840)





(707)



   Excess tax benefits from stock compensation



295





15



   Common stock repurchases



(568)





(5,447)



   Debt issue costs



--





(368)



         Net cash provided by financing activities



46,148





18,467



         Net (decrease) increase in cash and cash equivalents



(138,152)





5,400



Cash and cash equivalents, beginning of period



403,752





379,099



Cash and cash equivalents, end of period

$

265,600



$

384,499

















Supplemental disclosures of cash flow information:













   Interest paid

$

7,320



$

7,658



   Income taxes paid

$

27,940



$

31,512

















Supplemental disclosure of non-cash investing and financing activities:













   Contribution from noncontrolling interest

$

306



$

5,107









CENTENE CORPORATION

CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA



Q2



Q1



Q4



Q3



Q2



2010



2010



2009



2009



2009

MEMBERSHIP



















Managed Care:



















   Arizona

19,300



19,000



18,100



17,400



16,200

   Florida

113,100



105,900



102,600



84,400



22,300

   Georgia

295,600



301,000



309,700



303,400



292,800

   Indiana

212,700



211,400



208,100



200,700



196,100

   Massachusetts

30,100



26,900



27,800



500



   Ohio

159,300



156,000



150,800



151,200



141,200

   South Carolina

92,600



53,900



48,600



46,100



46,000

   Texas

475,500



459,600



455,100



450,200



443,200

   Wisconsin

133,600



134,900



134,800



132,500



131,200

       Total at-risk membership

1,531,800



1,468,600



1,455,600



1,386,400



1,289,000

   Non-risk membership

50,900



62,200



63,700



63,200



114,000

       TOTAL

1,582,700



1,530,800



1,519,300



1,449,600



1,403,000





















   Medicaid

1,135,500



1,088,300



1,081,400



1,040,000



958,600

   CHIP & Foster Care

272,400



266,300



263,600



263,400



261,400

   ABD & Medicare

93,800



87,100



82,800



82,500



69,000

   Other State programs

30,100



26,900



27,800



500



       Total at-risk membership

1,531,800



1,468,600



1,455,600



1,386,400



1,289,000

   Non-risk membership

50,900



62,200



63,700



63,200



114,000

       TOTAL

1,582,700



1,530,800



1,519,300



1,449,600



1,403,000





















Specialty Services(a):



















   Cenpatico Behavioral Health



















     Arizona

119,700



119,300



120,100



117,300



110,500

     Kansas

39,100



39,800



41,400



41,000



41,100

Bridgeway Health Solutions



















   Long-term Care

2,800



2,700



2,600



2,500



2,400

       TOTAL

161,600



161,800



164,100



160,800



154,000





















(a) Includes external membership only.







































REVENUE PER MEMBER PER MONTH(b)

$

208.58



$

215.95(c)



$

226.42



$

222.77



$

219.75





















CLAIMS(b)



















   Period-end inventory

480,400



341,400



423,400



414,900



362,200

   Average inventory

306,900



283,900



279,000



227,100



234,500

   Period-end inventory per member

0.31



0.23



0.29



0.30



0.28

(b) Revenue per member and claims information are presented for the Managed Care at-risk members.

(c) Reduction in revenue per member per month is a result of the pharmacy carve-outs in 2010.











Q2



Q1



Q4



Q3



Q2



2010



2010



2009



2009



2009





















DAYS IN CLAIMS PAYABLE



















Medical

47.2



46.6



48.1



47.1



47.5

Pharmacy

1.0



1.1



2.0



1.8



1.5

TOTAL

48.2



47.7



50.1



48.9



49.0

Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.





















CASH AND INVESTMENTS (in millions)

















Regulated

$

813.0



$

917.9



$

949.9



$

911.4



$

825.8

Unregulated



39.4





51.3





36.2





27.6





27.0

TOTAL

$

852.4



$

969.2



$

986.1



$

939.0



$

852.8





















DEBT TO CAPITALIZATION

24.5%



23.7%



33.2%



31.9%



33.0%

Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).  







Operating Ratios:



Three Months Ended

June 30,



Six Months Ended

June 30,



2010





2009



2010





2009

Health Benefits Ratios:



























 Medicaid and CHIP

83.4

%





83.7

%



84.5

%





84.2

%

 ABD and Medicare

86.5







82.6





83.4







82.0



 Specialty Services

81.7







79.8





81.2







79.0



 Total

83.8







83.1





83.9







83.3































Total General & Administrative Expense

Ratio

12.7

%





13.9

%



13.0

%





13.7

%







MEDICAL CLAIMS LIABILITY (In thousands)

The changes in medical claims liability are

summarized as follows:

Balance, June 30, 2009

$

406,834



Incurred related to:







Current period



3,427,022



Prior period



(59,502)



Total incurred



3,367,520



Paid related to:







Current period



2,980,741



Prior period



338,238



Total paid



3,318,979



Balance, June 30, 2010

$

455,375









Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability. Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period." As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the "Incurred related to: Prior period" above includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, increased receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to June 30, 2009.

SOURCE Centene Corporation

Copyright y 27 PR Newswire

Centene (NYSE:CNC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Centene Charts.
Centene (NYSE:CNC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Centene Charts.